Literature DB >> 6311451

Genotoxic effects in rodents given high oral doses of ranitidine and sodium nitrite.

G Brambilla, M Cavanna, P Faggin, A Maura, A Pino, R Ricci, L Robbiano.   

Abstract

The possible intragastric nitrosation of ranitidine to genotoxic derivatives has been investigated in rats and mice given, by gavage, high single doses of this histamine H2 receptor antagonist along with NaNO2. Liver DNA fragmentation, as revealed in rats by both DNA alkaline elution and DNA alkaline denaturation followed by hydroxylapatite chromatography, was found to be dependent either on the molar ratio drug/nitrite or on the gastric pH. It occurred only with doses of 175 mg/kg ranitidine HCl + 80 mg/kg NaNO2 (molar ratio 1:2.32) or 350 mg/kg ranitidine HCl + 80 mg/kg NaNO2 (molar ratio 1:1.16) and concurrent reduction of gastric pH from 5.5 to 2-3 (produced by prolonged fasting). A further reduction of pH elicited by histamine injection increased the amount of DNA damage. DNA fragmentation in gastric mucosa showed a similar dependence on both pH and ranitidine/NaNO2 ratio, but was more marked than in liver. Simultaneous administration of ascorbic acid reduced the damage of gastric DNA. Oral administration of 175 mg/kg ranitidine HCl + 80 mg/kg NaNO2 in fasted and histamine-injected mice induced a modest but statistically significant increase in the frequency of sister chromatid exchanges in bone marrow cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311451     DOI: 10.1093/carcin/4.10.1281

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  6 in total

Review 1.  H2-receptor antagonists and gastric cancer.

Authors:  J Penston; K G Wormsley
Journal:  Med Toxicol       Date:  1986 May-Jun

Review 2.  Effects of acid suppression on microbial flora of upper gut.

Authors:  N D Yeomans; R W Brimblecombe; J Elder; R V Heatley; J J Misiewicz; T C Northfield; A Pottage
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

3.  Pharmacoepidemiological Research on N-Nitrosodimethylamine-Contaminated Ranitidine Use and Long-Term Cancer Risk: A Population-Based Longitudinal Cohort Study.

Authors:  Chun-Hsiang Wang; I-I Chen; Chung-Hung Chen; Yuan-Tsung Tseng
Journal:  Int J Environ Res Public Health       Date:  2022-09-30       Impact factor: 4.614

4.  Effect of Oral Ranitidine on Urinary Excretion of N-Nitrosodimethylamine (NDMA): A Randomized Clinical Trial.

Authors:  Jeffry Florian; Murali K Matta; Ryan DePalma; Victoria Gershuny; Vikram Patel; Cheng-Hui Hsiao; Robbert Zusterzeel; Rodney Rouse; Kristin Prentice; Colleen Gosa Nalepinski; Insook Kim; Sojeong Yi; Liang Zhao; Miyoung Yoon; Susan Selaya; David Keire; Joyce Korvick; David G Strauss
Journal:  JAMA       Date:  2021-07-20       Impact factor: 56.272

5.  Evaluation of teratogenicity and genotoxicity induced by kramecyne (KACY).

Authors:  J M Cristóbal-Luna; N Paniagua-Castro; G N Escalona-Cardoso; M S Pérez-Gutiérrez; I Álvarez-González; E Madrigal-Bujaidar; G Chamorro-Cevallos
Journal:  Saudi Pharm J       Date:  2018-03-29       Impact factor: 4.330

6.  In Vitro Analysis of N-Nitrosodimethylamine (NDMA) Formation From Ranitidine Under Simulated Gastrointestinal Conditions.

Authors:  Zongming Gao; Michael Karfunkle; Wei Ye; Tim Andres Marzan; Jingyue Yang; Timothy Lex; Cynthia Sommers; Jason D Rodriguez; Xiaomei Han; Jeffry Florian; David G Strauss; David A Keire
Journal:  JAMA Netw Open       Date:  2021-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.